title: Lamivudine in renal transplant candidates with chronic hepatitis B infection.
authors.affiliation: Baskent University Faculty of Medicine, Ankara, Turkey. melekk@baskent-ank.edu.tr
authors.forename: S
authors.initials: S
authors.lastname: Boyacioglu
authors.forename: G
authors.initials: G
authors.lastname: Gür
authors.forename: M
authors.initials: M
authors.lastname: Gürsoy
authors.forename: N
authors.initials: N
authors.lastname: Ozdemir
mesh_terms: D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006514:Hepatitis B Surface Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D018937:Hepatitis C Antibodies / Q000097:blood; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012449:Safety
chemical_list: D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D018937:Hepatitis C Antibodies; D019259:Lamivudine; D000410:Alanine Transaminase